Igenomix Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 560

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 2

Igenomix General Information

Description

Provider of genetic testing services intended for reproductive health clinics. The company specializes in offering a range of services in reproductive genetics and specializes including NACE (non-invasive prenatal test), CGT (carrier genetic test), PGD (preimplantation genetic diagnosis), ERA (endometrial receptivity array) and creates and develops tools for the reproductive medicine field, thereby helping the clients couples who are trying to conceive.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 7955 Northwest 12th Street
  • Suite 415
  • Miami, FL 33126
  • United States
+1 (305)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 7955 Northwest 12th Street
  • Suite 415
  • Miami, FL 33126
  • United States
+1 (305)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Igenomix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Igenomix‘s full profile, request access.

Request a free trial

Igenomix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of genetic testing services intended for reproductive health clinics. The company specializes in offering a ran
Laboratory Services (Healthcare)
Miami, FL
560 As of 2021

Aliso Viejo, CA
 

South Plainfield, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Igenomix Competitors (37)

One of Igenomix’s 37 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ambry Genetics Formerly PE-Backed Aliso Viejo, CA
Admera Health Venture Capital-Backed South Plainfield, NJ
Exagen Formerly VC-backed Vista, CA
BGI Genomics Formerly VC-backed Shenzhen, China
MedGenome Venture Capital-Backed Wilmington, DE
You’re viewing 5 of 37 competitors. Get the full list »

Igenomix Patents

Igenomix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4416305-A2 Methods and reagents for the differential diagnosis of uterine tumors Pending 11-Oct-2021
US-20220220564-A1 Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas Pending 17-Apr-2019
EP-3956476-A1 Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas Inactive 17-Apr-2019
JP-2022529294-A Improved methods for early diagnosis of uterine leiomyoma and leiomyoma Pending 17-Apr-2019
US-20210269862-A1 Methods for assessing endometrial transformation Inactive 18-Jun-2018 C12Q1/6816
To view Igenomix’s complete patent history, request access »

Igenomix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Igenomix Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Igenomix‘s full profile, request access.

Request a free trial

Igenomix Investments (2)

Igenomix’s most recent deal was a Joint Venture with Novalbufera Business. The deal was made on 04-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novalbufera Business 04-Jun-2021 Joint Venture Other Commercial Products
Access Genomics 14-Dec-2020 Buyout/LBO Laboratory Services (Healthcare)
To view Igenomix’s complete investments history, request access »

Igenomix Exits (1)

Igenomix’s most recent exit was on 14-Dec-2020 from Access Genomics. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Access Genomics 14-Dec-2020 Completed
  • 4 buyers
To view Igenomix’s complete exits history, request access »

Igenomix FAQs

  • When was Igenomix founded?

    Igenomix was founded in 2011.

  • Where is Igenomix headquartered?

    Igenomix is headquartered in Miami, FL.

  • What is the size of Igenomix?

    Igenomix has 560 total employees.

  • What industry is Igenomix in?

    Igenomix’s primary industry is Laboratory Services (Healthcare).

  • Is Igenomix a private or public company?

    Igenomix is a Private company.

  • What is the current valuation of Igenomix?

    The current valuation of Igenomix is .

  • What is Igenomix’s current revenue?

    The current revenue for Igenomix is .

  • Who are Igenomix’s investors?

    Aleph Capital Partners, Amadeus Capital Partners, Charme Capital Partners, EQT, and are 5 of 7 investors who have invested in Igenomix.

  • Who are Igenomix’s competitors?

    Ambry Genetics, Admera Health, Exagen, BGI Genomics, and MedGenome are some of the 37 competitors of Igenomix.

  • When was Igenomix acquired?

    Igenomix was acquired on 30-Nov-2021.

  • Who acquired Igenomix?

    Igenomix was acquired by Vitrolife.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »